« Return to News | Drug Sponsors

Pfizer plans to sell Capsugel unit

Tuesday, April 5, 2011 02:57 PM

Pfizer has plans to sell its Capsugel unit to an affiliate of investment firm Kohlberg Kravis Roberts (KKR) for nearly $2.4 billion in cash.  Pfizer’s plans to divest the division to narrow its business focus have been known for a while, according to Pharma Times.

As a result of the Capsugel sale, Pfizer has lowered its sales expectations for the year, given that Capsugel," a world leader in hard capsules and an innovator in drug-delivery systems," pulled in revenues of around $750 million last year.

Henry Kravis and George Roberts, co-founders, chairmen and chief executive of KKR, explained the firm's interest in the deal and highlighted Capsugel's "excellent portfolio and outstanding reputation for providing high-quality, innovative drug-delivery solutions."   They said shared the group's "enthusiasm for its future potential to grow, develop and continue to deliver an unmatched quality of products."

The transaction is expected to close sometime during the third quarter, assuming all customary closing conditions are satisfied.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.